April 17, 2018 / 8:15 PM / 7 months ago

BRIEF-Oncolytics Biotech Chief Medical Officer To Leave Effective April 23

1 Min Read

April 17 (Reuters) - Oncolytics Biotech Inc:

* ONCOLYTICS BIOTECH(R) ANNOUNCES MANAGEMENT CHANGE

* ONCOLYTICS BIOTECH INC - ANDRES GUTIERREZ, CHIEF MEDICAL OFFICER WILL BE LEAVING EFFECTIVE APRIL 23, 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

© 2018 Reuters. All Rights Reserved.